Showing 5871-5880 of 21466 results for "".
- Beauty Rep Launches Digital Platform to Modernize Brand-Practice Collaborationhttps://reachmd.com/news/beauty-rep-launches-digital-platform-to-modernize-brand-practice-collaboration/2484439/A new digital platform, Beauty Rep, has launched to streamline the way aesthetic brands and practices collaborate, aiming to reduce operational inefficiencies in sales, marketing, and education. Founded by aesthetics industry veterans, Beauty Rep provides a centralized hub for brand-practi
- Social Determinants in Adolescent Mental Health: A Call for Effective Screening Strategieshttps://reachmd.com/news/social-determinants-in-adolescent-mental-health-a-call-for-effective-screening-strategies/2484415/ABCD cohort analyses identify family conflict and peer reputational harm among the strongest social predictors of adolescent mental-health risk. Machi
- Understanding the Link Between Ultra-Processed Foods and Prediabetes in Young Adultshttps://reachmd.com/news/understanding-the-link-between-ultra-processed-foods-and-prediabetes-in-young-adults/2484405/Ultra-processed foods are linked to a measurable rise in early metabolic risk: a reported 10% relative increase in intake corresponded to a substantially higher incidence of prediabetes in young adults—an effect size with immediate relevance for screening in this age group.
- Advances in T-Cell Therapy for HPV-Driven Cancers: A Clinical Updatehttps://reachmd.com/news/advances-in-t-cell-therapy-for-hpv-driven-cancers-a-clinical-update/2484414/Notably, HPV T-cell therapy produced clinically meaningful responses in a small phase II cohort of patients with advanc
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://reachmd.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t
- PlasmaGLO HALO Mask Expands LED Therapy to Face, Neck, and Scalphttps://reachmd.com/news/plasmaglo-halo-mask-expands-led-therapy-to-face-neck-and-scalp/2484403/Rajani MD has announced the release of the PlasmaGLO HALO Mask, a second-generation at-home LED light therapy device intended to treat signs of aging across the face, neck, and scalp. The new device builds on the brand’s original PlasmaGLO LED Mask by expanding treatment zones to include the hair
- Advancing Health Equity: The Global Partnership Between Nestlé Health Science and Special Olympicshttps://reachmd.com/news/advancing-health-equity-the-global-partnership-between-nestle-health-science-and-special-olympics/2484422/In a major step toward health equity for individuals with intellectual and developmental disabilities (IDD),
- ctDNA: Transforming Adjuvant Therapy in Bladder Cancerhttps://reachmd.com/news/ctdna-transforming-adjuvant-therapy-in-bladder-cancer/2484394/The IMvigor011 trial suggests postoperative circulating tumor DNA (ctDNA) testing can meaningfully guide adjuvant immunotherapy decisions after cystectomy. Compared with clinicopath
- Large Study Shows No Link Found Between Pemphigus and Psychiatric Disordershttps://reachmd.com/news/large-study-shows-no-link-found-between-pemphigus-and-psychiatric-disorders/2484421/Results from a large retrospective cohort study analyzing more than 120 million U.S. electronic health records found no increased risk of psychiatric disorders in patients with pemphigus. "While 10–15% of dermatology patients ar
- FDA's Path Forward for RP1: Acceptance of BLA Resubmission Marks a Milestone in Advanced Melanoma Treatmenthttps://reachmd.com/news/fdas-path-forward-for-rp1-acceptance-of-bla-resubmission-marks-a-milestone-in-advanced-melanoma-treatment/2484353/The FDA has accepted the RP1 BLA resubmission, initiating a formal review of RP1 (vusolimogene oderparepvec) in combi